Twenty-five of the nation's foremost experts in global health have been named to the third class of Ambassadors in Research!America's Paul G. Rogers Society for Global Health Research. The Society, named for The Honorable Paul G. Rogers (D), former Florida Congressman, renowned champion for health research and former Research!America chair, aims to increase awareness of and make the case for greater U.S. investment in research to fight diseases that disproportionately affect the world's poorest nations.
Click on the Ambassadors' photos or names to read their profiles.
Linda H. Aiken, PhD, RN
"There is nothing more powerful in building geopolitical partnerships and fostering the growth of democracy in parts of the world that don't have them by working together on health."
Michele Barry, MD
"What our country does best is health care and health care research. US-funded global health research is our mechanism for partnership and global health diplomacy."
Barry Beaty, PhD
"We live in a global economy, one where our own country and pocketbooks function best when other countries' economies are robust and well connected. We are starting to have a real understanding that we are not an island anymore, that any disease can reach us in 24 hours. U.S. investment and international partnerships are needed to protect us from global health diseases."
David Bloom, PhD
"The United States should increase its investment in global heatlh research because population health is the cornerstone of a strong economy and geopolitical stability is based on the ‘rising tide that lifts all boats.'"
Jacquelyn Campbell, PhD, RN
"Women are dying from domestic homicide AND from HIV/AIDS at alarming rates - not just abroad, but right here in our neighborhoods, especially women of color. We can prevent this. Global health research affords us the opportunity to do just that, and save lives of women everywhere."
Daniel G. Colley, PhD
"What happens in Kenya affects us here in Georgia, not only in direct health benefits, but also in direct economic and security terms. We live in a global village and if we don't tackle health now, we will have to tackle much more than that later."
Frank H. Collins, PhD
"Millions of people around the world are dying from diseases rare to the U.S. The need for investment in global health research is crucial — the point here is not how prevalent these diseases are in the U.S. but how aware Americans are of these stark and stunning disparities and that there are simple life-saving interventions that are and can continue to be developed and implemented with committed support."
Walter R. Dowdle, PhD
"Public health threats abroad are public health threats here."
Cyril Enwonwu, ScD, PhD, MDS
"Global health research is Baltimore, and global health research is Africa."
Pierce Gardner, MD
"Global health is sweeping the interest of young people. This generation knows a very different world than previous generations... Today, through globalization, technology and easier means of travel, the world is brought right before our eyes. As a result, young people see the global health and social disparities that exist, and they feel morally responsible and pbliged to respond to this."
Anne Goldfeld, MD
"TB is a worldwide problem and impacts us all. Understanding how pathogens and human immune responses work applies to all of us regardless of where we live."
Patricia Hibberd, MD, PhD
"We have so much knowledge to give about these diseases, but what's the point of having this information if we don't know how to deliver these effective interventions at the critical, rural community level to cause real change — we need increased investment in global health research to ensure that happens."
Adnan A. Hyder, MD, MPH, PhD
"An investment in injury prevention research is an important step in better global health as well as building diplomacy. Global injury prevention is all about global security and we must take steps to invest in what we already know works and continue to invest in research to save lives."
James Kazura, MD
"We are a global world, and there are no U.S. ‘customs and border checkpoints' for infectious diseases."
Kelli Kuhen, PhD
"There have been no new drugs in the last 40 years for treatment of tuberculosis, and drug-resistant strains are on the rise. With medicines that currently take six months to be effective, what this means is that people die. We need funding for research and for better translation of the basic research into making the drug. We cannot treat patients with publications!"
Richard Love, MD
"Personalized medicine...is the future of better health. And the only way to learn this is by studying diverse populations of people. This is a win-win situation for everyone."
Carole Mitnick, ScD
"Our research demonstrates that extensively drug resistant TB need not be considered a death sentence. With comprehensive, patient-centered, community-based care as part of an effective national TB program, this disease can be cured, even in poor areas. Significant research is required, however, to improve the likelihood of cure, which occurs in 60% of patients at most."
Keith Norris, MD
"There are valuable lessons the U.S. can learn from health research and solutions in other countries — especially for our under- and uninsured populations."
Richard Parker, PhD
"As the richest nation in the world..., the United States is unquestionably the key point of reference for other nations, as well as for private-sector organizations and individuals, in evaluating their own contributions to the global effort to respond to HIV/AIDS and other major international health problems. ... We cannot lose the chance to reaffirm a vision of health as a fundamentally public good, or that questions of health can never be separated from broader struggles for responsibility, fairness and social justice."
Mark Rasenick, PhD
"Global science transcends politics. It gets different people from all over the world working together to solve a personal issue that connects us all: our health. It proves that political boundaries can be overcome."
Scott Ratzan, MD
"How can we help shape the future of health care as a solution provider, rather than using the outdated architecture that's already in place? Talking about what we do as global health researchers, developing a health-literate society and what it means for America is vital to continued support for providing these solutions — it's no small task."
Steven G. Reed, PhD
"Public private partnerships have been essential to creating and providing us with vaccines and diagnostics — a true cost-effective investment and intervention in our nation's health and economic well-being."
Lee Reichman, MD, MPH
"We must raise consciousness about the seriousness of TB. When we turned our backs before, the disease showed back up at our door. We cannot afford to do the same again — the risks are too high. We all have a serious stake in this matter, and we all need to get on board. To control TB anywhere, you have to control it everywhere."
Mark L. Rosenberg, MD
"About 1.2 million people are killed on the roads every year. People think that these are 'accidents' that can't be stopped or changed... Imagine several people on a 4-inch beam being told to get across 'carefully' and without colliding into the others. Well, any 'accident' that occurs could have easily been prevented by widening that bean to 4-feet. These deaths and injuries are predictable and preventable."
Mathuram Santosham, MD, MPH
"We underestimate what we can do. The research lessons learned in other countries can be applied to any city in the U.S. And by empowering communities abroad, we learn how to empower people in our own communities."